Fatal late-onset EBV-associated post transplant lymphoproliferative disease after umbilical cord blood transplantation due to persistent mixed chimerism and severe delay in T-cell recovery in patient with Omenn's syndrome [7]

Bone Marrow Transplantation

Volumn 34, Issue 3, 2004, Pages 283-284

  Meyer Bahlburg, A ^a   Winkler, J ^b   Meerbach, A ^c   Holzhausen, H J ^d   Wawer, A ^a,e   Diwan, O ^a   Wutzler, P ^c   Horneff, G ^a   Burdach, S ^a,e  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY CD3; RITUXIMAB; THYMOCYTE ANTIBODY;

AUTOPSY; CASE REPORT; CORD BLOOD STEM CELL TRANSPLANTATION; EPSTEIN BARR VIRUS; FOLLOW UP; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LYMPHOPROLIFERATIVE DISEASE; MALE; OMENN SYNDROME; OUTCOMES RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; FETAL BLOOD; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; POSTOPERATIVE COMPLICATIONS; SEVERE COMBINED IMMUNODEFICIENCY; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 4344622169     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704564     Document Type: Letter

References (7)

1. Shapiro RS, McClain K, Frizzera G et al. EBV associated B cell lymphoproliferative disease following bone marrow transplantation. Blood 1988; 71: 1234-1243.
2. Barker JN, Martin PL, Coad JE et al. Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients. Biol Blood Marrow Transplant 2001; 7: 395-399.
3. Bhatia S, Ramsay NKC, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation. Blood 1996; 87: 3633-3639.
4. Curtis RE, Travis LB, Rowlings PA et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208-2216.
5. Gross TG, Steinbuch M, DeFor T et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant 1999; 23: 251-258.
6. Meyer-Bahlburg A, Haas JP, Haase R et al. Successful treatment of erythrodermia and alopecia with cyclosporin A in an infant with Omenn's syndrome. Arch Dis Child 2002; 87: 231-234.
7. Filipovich AH. Stem cell transplantation from unrelated donors for correction of primary immunodeficiencies. Immunol Allergy Clin N Am 1996; 16: 377-392.